EP0822980A4 - Virus de la laryngotracheite infectieuse recombine et ses utilisations - Google Patents

Virus de la laryngotracheite infectieuse recombine et ses utilisations

Info

Publication number
EP0822980A4
EP0822980A4 EP96910515A EP96910515A EP0822980A4 EP 0822980 A4 EP0822980 A4 EP 0822980A4 EP 96910515 A EP96910515 A EP 96910515A EP 96910515 A EP96910515 A EP 96910515A EP 0822980 A4 EP0822980 A4 EP 0822980A4
Authority
EP
European Patent Office
Prior art keywords
infectious laryngotracheitis
gene
laryngotracheitis virus
virus
recombinant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP96910515A
Other languages
German (de)
English (en)
Other versions
EP0822980A1 (fr
Inventor
Martha A Wild
Mark D Cochran
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syntro Corp
Original Assignee
Syntro Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntro Corp filed Critical Syntro Corp
Publication of EP0822980A1 publication Critical patent/EP0822980A1/fr
Publication of EP0822980A4 publication Critical patent/EP0822980A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

L'invention concerne un virus de laryngotrachéite infectieuse recombinée atténué comprenant le génome viral de la laryngotrachéite infectieuse, lequel contient une déletion dans le gène de la glycoprotéine gG. Ce virus atténué est utile en tant que vaccin contre le virus de la laryngotrachéite infectieuse. L'invention concerne également un virus de laryngotrachéite infectieuse recombiné atténué comprenant le génome viral de laryngotrachéite infectieuse, lequel contient une déletion dans le gène US2, le gène de type UL47, le gène ORF4 ou le gène de la glycoprotéine G60. En outre, l'invention concerne un procédé permettant de distinguer les poulets ou autres volailes vaccinés par un virus de laryngotrachéite infectieuse recombiné, lequel ne produit pas de glycoprotéine gG, de ceux contaminés par le virus de laryngotrachéite infectieuse naturel.
EP96910515A 1995-03-23 1996-03-21 Virus de la laryngotracheite infectieuse recombine et ses utilisations Withdrawn EP0822980A4 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US410121 1982-08-20
US41012195A 1995-03-23 1995-03-23
US46819095A 1995-06-06 1995-06-06
US468190 1995-06-06
PCT/US1996/003916 WO1996029396A1 (fr) 1995-03-23 1996-03-21 Virus de la laryngotracheite infectieuse recombine et ses utilisations

Publications (2)

Publication Number Publication Date
EP0822980A1 EP0822980A1 (fr) 1998-02-11
EP0822980A4 true EP0822980A4 (fr) 2000-04-26

Family

ID=27020873

Family Applications (1)

Application Number Title Priority Date Filing Date
EP96910515A Withdrawn EP0822980A4 (fr) 1995-03-23 1996-03-21 Virus de la laryngotracheite infectieuse recombine et ses utilisations

Country Status (4)

Country Link
EP (1) EP0822980A4 (fr)
JP (1) JP3964458B2 (fr)
CA (1) CA2216139C (fr)
WO (1) WO1996029396A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8821441D0 (en) 1988-09-13 1988-10-12 Animal Health Inst Viral vectors
FR2750866B1 (fr) * 1996-06-27 1998-11-27 Rhone Merieux Vaccin vivant recombinant aviaire, utilisant comme vecteur le virus de la laryngotracheite infectieuse aviaire
FR2757061B1 (fr) * 1996-12-16 1999-03-26 Rhone Merieux Vaccin vivant recombinant aviaire, utilisant comme vecteur le virus de la laryngotracheite infectieuse aviaire
AU2003270824B2 (en) 2002-09-18 2009-02-19 The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services Recovery of recombinant human parainfluenza virus type 2 (HPIV2) from cDNA and use of recombinant HPIV2 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens
EP2768529A1 (fr) 2011-10-21 2014-08-27 Intervet International B.V. Vecteur mdv non pathogène recombinant conférant une immunité multivalente
CN107805631B (zh) 2011-10-21 2021-10-01 英特维特国际股份有限公司 编码传染性喉气管炎病毒和新城疫病毒抗原的重组非致病性马立克氏病病毒构建体
KR102617503B1 (ko) 2016-12-14 2023-12-29 뵈링거 잉겔하임 애니멀 헬스 유에스에이 인코포레이티드 조류 병원체의 다중 항원을 발현하는 재조합 hvt 벡터 및 그를 포함하는 백신
CN109609468B (zh) * 2018-12-10 2020-06-30 畜科生物工程有限公司 一种六基因缺失的猪伪狂犬病毒、猪伪狂犬病疫苗以及制备方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995008622A1 (fr) * 1993-09-24 1995-03-30 Syntro Corporation Virus de recombinaison de la laryngotracheite infectieuse et utilisations desdits virus

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0434747B1 (fr) * 1988-09-13 1999-05-19 Merial VACCINS RECOMBINANTS A BASE DE LA PROTEINE gB DU VIRUS DE LA MALADIE DE MAREK
WO1991002053A1 (fr) * 1989-08-01 1991-02-21 Arthur Webster Pty. Ltd. Virus de laryngotracheite (ilt) a virulence reduite pour la vaccination d'oiseaux
DE69101683T2 (de) * 1990-07-30 1994-07-21 Akzo Nv Rekombinantes Mareks-Krankheitsvirus.
WO1992003554A1 (fr) * 1990-08-24 1992-03-05 Arthur Webster Pty. Ltd. Vaccin contre le virus de la laryngotracheite infectieuse
US6087127A (en) * 1990-08-24 2000-07-11 Board Of Trustees Operating Michigan State University Marek's disease herpesvirus DNA segment encoding glycoproteins, gD, gI and gE

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995008622A1 (fr) * 1993-09-24 1995-03-30 Syntro Corporation Virus de recombinaison de la laryngotracheite infectieuse et utilisations desdits virus

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
GUO P. ET AL.: "Construction of recombinant avian infectious laryngotracheitis virus expressing the beta-galactosidase gene and DNA sequencing of the insertion region", VIROLOGY, vol. 202, 1994, pages 771 - 781, XP002131399 *
KONGUSUWAN K. ET AL.: "Nucleotide sequence analysis of an infectious layngotracheitis virus gene corresponding to the US3 of HSV-1 and a unique gene encoding a 67 kDa protein.", ARCH. VIROL., vol. 140, no. 1, January 1995 (1995-01-01), pages 27 - 39, XP000877135 *
See also references of WO9629396A1 *
WILD M A ET AL: "A GENOMIC MAP OF INFECTIOUS LARYNGOTRACHEITIS VIRUS AND THE SEQUENCE AND ORGANIZATION OF GENES PRESENT IN THE UNIQUE SHORT AND FLANKING REGIONS", VIRUS GENES,US,KLUWER ACADEMIC PUBLISHERS, BOSTON, vol. 12, no. 2, 1 January 1996 (1996-01-01), pages 107 - 116, XP000645840, ISSN: 0920-8569 *
ZELNIK V. ET AL.: "The complete sequence and gene organization of the short unique region of herpesviru of turkeys", J. GEN. VIROL., vol. 74, 1993, pages 2151 - 2162, XP002131400 *

Also Published As

Publication number Publication date
EP0822980A1 (fr) 1998-02-11
JP3964458B2 (ja) 2007-08-22
CA2216139C (fr) 2013-01-08
WO1996029396A1 (fr) 1996-09-26
CA2216139A1 (fr) 1996-09-26
AU5369096A (en) 1996-10-08
JPH11503009A (ja) 1999-03-23
AU721451B2 (en) 2000-07-06

Similar Documents

Publication Publication Date Title
CA2166367A1 (fr) Vaccin recombinant vivant pour oiseaux, utilisant un virus herpetique aviaire comme vecteur
PL333070A1 (en) Infectious clones of rna viruses and vaccines based on them
AU5562798A (en) Recombinant live avian vaccine, using as vector the avian infectious laryngotracheitis virus.
PT870046E (pt) Vacina viva recombinante à base de herpesvírus felino de tipo 1, especialmente contra a peritonite infecciosa felina
EP1298139A3 (fr) Vaccin récombinant contre la bursite infectieuse basé sur un virus herpès aviaire
AU3448797A (en) Avian recombinant live vaccine using, as vector, the avian infectious laryngotracheitis virus
AU6217798A (en) Avian recombinant live vaccine using, as vector, the avian infectious laryngotracheitis virus
GR3035135T3 (en) Poultry vaccine containing infections bronchitis virus serotype 4/91.
HU9201746D0 (en) Recombinant avipox virus, the virus infected cell cultivation and the vaccine resulted from it for poultry vaccination
SG55095A1 (en) Viruses and their use as a vaccine against feline infectious peritonitis virus disease
EP0597016A4 (en) Infectious bursal disease virus recombinant poxvirus vaccine.
MY115070A (en) Porcine reproductive and respiratory syndrome vaccine
MXPA03000061A (es) Manipulacion de virus de arn encadenados negativos mediante redisposicion de sus genes y usos de los mismos.
AU1521492A (en) Recombinant varicella-zoster virus and process for constructing same
GB2376687A (en) Herpes viruses for immune modulation
WO1995012682A3 (fr) Vecteur viral a antigenes du virus de la maladie des muqueuses (bvdv)
WO2000034445A3 (fr) Vaccin vivant attenue de l'encephalomyelite equine du venezuela
WO1994000586A3 (fr) Mutants et vaccins du virus de la rhinotracheite infectieuse bovine
CA2359177A1 (fr) Vaccin a base de bhv-1 a deletion de gene
CA2198743A1 (fr) Vaccin de la peritonite infectieuse feline
NO20005482L (no) Rekombinant virus og anvendelser derav samt vaksine som omfatter nevnte virus.
WO1989010965A3 (fr) Glycoproteine h des virus herpetiques
WO2002009750A3 (fr) Vaccins pour le type 1 du virus herpetique equin: mutations hebergeant les virus dans le gene precoce immediat
NZ511168A (en) Recombinant CELO virus and CELO virus DNA
WO1998004710A3 (fr) Vaccin recombine vivant contre l'herpes virus bovin/le virus respiratoire syncytial bovin

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19971023

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 20000315

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 20020719

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20021202